RNS Number : 2384A

Genus PLC

22 December 2017

22 December 2017

Genus plc

Director/PDMR Shareholding

Genus plc (LSE: GNS) announces that, further to the vesting of conditional nil-cost options on 20 November 2017 under the Genus Deferred Share Bonus Plan (the 'DSBP') as listed in table A below, the Executive Directors and members of the Genus Executive Leadership Team ('GELT') sold ordinary shares in Genus on 19 December 2017, on the London Stock Exchange to offset income tax and social security liabilities due on the exercises, and retained the balance of ordinary shares where applicable.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the number of nil-cost options exercised and ordinary shares sold on 19 December 2017.

For further information please contact:

Genus:

Cara Crichton, Deputy Company Secretary                                                                           Tel: +44 (0)1256 347100

Table A - GELT Deferred Share Bonus Plan Exercises  

1.   

Details of the person discharging managerial responsibilities / person closely associated

a.            

Name

1.    Karim Bitar

2.    Stephen Wilson

3.    Jonathan Lightner

2.           

Reason for the notification

a.           

Position/status

1.    Chief Executive

2.    Group Finance Director

3.    Chief Scientific Officer & Head of Genus R&D

b.           

Initial notification

/Amendment

Initial notification

3.           

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.           

Name

Genus plc

b.          

LEI

54930022EOITNKSIGH56

4.           

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.           

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.           

Nature of the transaction

1.    Exercise of 4,648 nil-cost options under the DSBP.

2.    Exercise of 3,445 nil-cost options under the DSBP.

3.    Exercise of 905 nil-cost options under the DSBP.

c.            

Price(s) and volume(s)

Price(s)	Volume(s)
1.    0p	4,648
2.    0p	3,445
3.    0p	905

d.           

Aggregated information

·     Aggregated volume

·     Price

Average price(s)	Total volume(s)
1.    0p	4,648
2.    0p	3,445
3.    0p	905

e.           

Date of the transaction

2017-12-19

f.            

Place of the transaction

Outside a trading venue.

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.   

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

GB0002074580

b.   

b.

Nature of the transaction

1.    Sale of 2,192 shares arising from the exercise of nil-cost options under the DSBP to offset income tax and social security liabilities due on the exercise.

2.    Sale of 1,625 shares arising from the exercise of nil-cost options       under the DSBP to offset income tax and social security liabilities due on the exercise.

3.    Sale of 905 shares arising from the exercise of nil-cost options under the DSBP partly to offset income tax and social security liabilities due on the exercise.

c.    

c.

Price(s) and volume(s)

Price(s)	Volume(s)
1.    2,552.5p	2,192
2.    2,552.5p	1,625
3.    2,552.5p	905

d.   

d.

Aggregated information

·     Aggregated volume

·     Price

Average price(s)	Total volume(s)
1.    2,552.5p	2,192
2.    2,552.5p	1,625
3.    2,552.5p	905

e.

Date of the transaction

2017-12-19

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

This information is provided by RNS

The company news service from the London Stock Exchange

END DSHUUUARBNAUUAA